BAX vs. BSX: Baxter vs. Boston Scientific Stock Comparison
How do Baxter (BAX) and Boston Scientific (BSX) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Baxter (BAX) and Boston Scientific (BSX) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.
| Profile Item | BAX | BSX |
|---|---|---|
| Name | Baxter International Inc. | Boston Scientific Corp. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Equipment | Health Care Equipment |
| Market Capitalization | 13.34 billion USD | 61.96 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | October 27, 1981 | May 19, 1992 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | BAX | BSX |
|---|---|---|
| Total Return (1Y) | 45.72% | -55.98% |
| Total Return (3Y, Annualized) | -5.53% | -5.05% |
| Total Return (5Y, Annualized) | -17.96% | 0.57% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | BAX | BSX |
|---|---|---|
| Volatility (1Y, Annualized) | 42.31% | 40.16% |
| Beta (5Y) | 0.62 | 0.57 |
| Max Drawdown (5Y) | -80.61% | -61.55% |
| Avg. Volume (3M) | 6.53M | 19.73M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | BAX | BSX |
|---|---|---|
| Sharpe Ratio (1Y) | 0.98 | -1.50 |
| Sortino Ratio (1Y) | 1.42 | -1.80 |
Profitability
ROE (TTM)
Baxter (BAX) reports a negative ROE of -9.04%; negative ROE can reflect losses or negative shareholders’ equity, so it is harder to read as capital efficiency. Meanwhile Boston Scientific (BSX) reports 14.12%, ranking against industry peers normally.
BAX
Health Care Equipment & Services industry group
-9.04%
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- BAX
- -9.04%
- Q1
- -10.67%
- Min
- -47.01%
BSX
Health Care Equipment & Services industry group
14.12%
- Max
- 47.61%
- Q3
- 14.36%
- BSX
- 14.12%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
Baxter (BAX) reports a negative net margin of -6.23%, usually indicating a net loss over the period. Meanwhile Boston Scientific (BSX) reports 16.62%, ranking against industry peers normally.
BAX
Health Care Equipment & Services industry group
-6.23%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- BAX
- -6.23%
- Q1
- -6.29%
- Min
- -28.46%
BSX
Health Care Equipment & Services industry group
16.62%
- Max
- 29.35%
- BSX
- 16.62%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Boston Scientific (BSX) at 19.05% operates in the top operating margin quartile, ahead of Baxter (BAX) at 9.88%, which runs around its industry’s norm.
BAX
Health Care Equipment & Services industry group
9.88%
- Max
- 35.43%
- Q3
- 14.14%
- BAX
- 9.88%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
BSX
Health Care Equipment & Services industry group
19.05%
- Max
- 35.43%
- BSX
- 19.05%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | BAX | BSX |
|---|---|---|
| ROE (TTM) | -9.04% | 14.12% |
| ROA (TTM) | 2.71% | 5.87% |
| Net Margin (TTM) | -6.23% | 16.62% |
| Operating Margin (TTM) | 9.88% | 19.05% |
| Gross Margin (TTM) | 33.37% | 67.98% |
Growth
Revenue Growth
Both Baxter (BAX) at 5.72% and Boston Scientific (BSX) at 19.87% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
Only one side can be read here: Boston Scientific (BSX) reports EPS growth of 55.20%, ranked against its industry; Baxter (BAX) has no EPS growth figure this period.
Growth Metrics
| Metric | BAX | BSX |
|---|---|---|
| Revenue Growth (YoY) | 5.72% | 19.87% |
| Revenue Growth (3Y CAGR) | 3.79% | 16.54% |
| EPS Growth (YoY) | -- | 55.20% |
| EPS Growth (3Y CAGR) | -- | 62.75% |
Financial Strength
Current Ratio (MRQ)
Baxter (BAX) at 1.79 keeps current ratio within its industry’s typical mid-range, while Boston Scientific (BSX) at 1.37 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for BSX.
BAX
Health Care Equipment & Services industry group
1.79
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- BAX
- 1.79
- Q1
- 1.37
- Min
- 0.30
BSX
Health Care Equipment & Services industry group
1.37
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- BSX
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Boston Scientific (BSX) at 0.46 carries an industry-typical debt-to-equity mix, while Baxter (BAX) at 1.36 uses more debt funding than most peers.
BAX
Health Care Equipment & Services industry group
1.36
- Max
- 1.88
- BAX
- 1.36
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
BSX
Health Care Equipment & Services industry group
0.46
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- BSX
- 0.46
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | BAX | BSX |
|---|---|---|
| Current Ratio (MRQ) | 1.79 | 1.37 |
| Debt / Equity (MRQ) | 1.36 | 0.46 |
| Net Debt / EBITDA | 3.73 | 2.04 |
Dividends
Dividend Yield (TTM)
Boston Scientific (BSX) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Baxter (BAX) reports a yield of 0.16%, ranking against industry peers normally.
BAX
Health Care Equipment & Services industry group
0.16%
- BAX
- 0.16%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
BSX
Health Care Equipment & Services industry group
0.00%
- BSX
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Baxter (BAX) reports payout ratio above 100% at 154.67%, meaning dividends exceeded current-period earnings; Boston Scientific (BSX) pays no dividend (payout 0.00%).
BAX
Health Care Equipment & Services industry group
154.67%
- BAX
- 154.67%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
BSX
Health Care Equipment & Services industry group
0.00%
- BSX
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | BAX | BSX |
|---|---|---|
| Dividend Yield (TTM) | 0.16% | 0.00% |
| Dividend Payout Ratio (TTM) | 154.67% | 0.00% |
Valuation
P/E Ratio (TTM)
An earnings multiple is available for just one side: Boston Scientific (BSX) trades at 18.04 times trailing earnings, ranked against its peers, while Baxter (BAX) has no P/E ratio this period.
BAX
Health Care Equipment & Services industry group
--
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
- BAX
- --
BSX
Health Care Equipment & Services industry group
18.04
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- BSX
- 18.04
- Min
- 4.21
P/S Ratio (TTM)
On P/S ratio, both Baxter (BAX) at 1.15 and Boston Scientific (BSX) at 2.94 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.
BAX
Health Care Equipment & Services industry group
1.15
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- BAX
- 1.15
- Q1
- 1.10
- Min
- 0.03
BSX
Health Care Equipment & Services industry group
2.94
- Max
- 8.80
- Q3
- 4.32
- BSX
- 2.94
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
On P/B ratio, both Baxter (BAX) at 2.05 and Boston Scientific (BSX) at 2.42 are valued close to their industries’ norm against book — neither stands out from peers.
BAX
Health Care Equipment & Services industry group
2.05
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- BAX
- 2.05
- Q1
- 1.73
- Min
- -1.31
BSX
Health Care Equipment & Services industry group
2.42
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- BSX
- 2.42
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | BAX | BSX |
|---|---|---|
| P/E Ratio (TTM) | -- | 18.04 |
| P/S Ratio (TTM) | 1.15 | 2.94 |
| P/B Ratio (MRQ) | 2.05 | 2.42 |
| Free Cash Flow Yield (TTM) | 9.16% | 4.02% |